BioForce Nanosciences Holdings, Inc. (BFNH)
OTCMKTS · Delayed Price · Currency is USD
4.092
+0.442 (12.11%)
At close: Sep 1, 2026

BFNH Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1371910595835
Market Cap Growth
381.92%93.83%-83.01%1.00%65.83%215.79%
Enterprise Value
1371910595835
Last Close Price
4.090.580.342.011.991.20

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
59.60-31.32-4.34-32.34-43.24-40.76

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
--0.16-0.12-0.12-0.13-0.13
Net Debt / Equity Ratio
0-0.16-0.12-0.12-0.13-0.12
Quick Ratio
0.000.00000.000.01
Current Ratio
25.410.00000.000.01
Return on Assets (ROA)
-32.12%-37162.50%-40869.73%-42998.69%-5109.38%-1230.04%
Return on Capital Employed (ROCE)
-26.60%79.20%21.30%25.90%36.00%58.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-0.07%-6.67%-4.91%-0.80%-0.83%-1.43%
Buyback Yield / Dilution
-7.89%-13.44%----79.53%